Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 04, 2026
3 Cathie Wood Stocks for a $150 Billion Market That's Just Forming
06:16am, Thursday, 13'th May 2021
Falling costs are ushering in a new era of screening for a dreaded disease.
This Under-the-Radar Healthcare Company Quietly Surged During the Pandemic
10:15am, Friday, 07'th May 2021
CareDx just posted 76% year-over-year revenue growth for the first quarter and raised its 2021 guidance.
Buying This Beaten-Down ETF Could Make You a Fortune Over the Next 10 Years
05:52am, Friday, 07'th May 2021
It definitely made investors a lot of money over the last decade. And its future could be brighter than the past.
Exact Sciences (EXAS) Q1 Earnings Top Estimates, Margins Down
09:24am, Wednesday, 05'th May 2021
Exact Sciences' (EXAS) first-quarter 2021 revenues improved year over year led by growth in Precision Oncology, COVID-19 testing and Screening revenues.
Exact Sciences Beat Expectations in Q1: Why Investors Didn't Jump for Joy
06:01am, Wednesday, 05'th May 2021
There was a big asterisk with the company's improved bottom line.
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q1 2021 Results - Earnings Call Transcript
10:58pm, Tuesday, 04'th May 2021
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q1 2021 Results - Earnings Call Transcript
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates
06:02pm, Tuesday, 04'th May 2021
Exact Sciences (EXAS) delivered earnings and revenue surprises of 82.69% and 4.50%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
These Are ARK Invest's 10 Top April Holdings
11:05am, Tuesday, 04'th May 2021
ARK Invest has been one of the most popular themes of late in the markets, outperforming many other funds and solidifying its place among the big players in the investments world.
Exact Sciences to participate in May investor conferences
06:00am, Monday, 03'rd May 2021
MADISON, Wis., May 3, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors to participat
ARK Genomic Revolution ETF: Value Realization Will Take Time
04:46am, Monday, 03'rd May 2021
ARK Genomic Revolution ETF: Value Realization Will Take Time
Cologuard® CRC Screening Test Most Cost-Effective Test in Medically Underserved Alaska Native People
06:00am, Wednesday, 28'th Apr 2021
MADISON, Wis., April 28, 2021 /PRNewswire/ -- Exact Sciences (NASDAQ: EXAS) today announces study results published in Mayo Clinic Proceedings showing that Cologuard (mt-sDNA) is the most cost-effect
Exact Sciences: New Acqusitions Aim To Unlock Strategic Value
11:43am, Monday, 26'th Apr 2021
Exact Sciences Corporation is a leader in global cancer screening and diagnostics and is undertaking rapid global expansion through several new acquisitions. Exact Sciences offers a variety of advance
3 High-Growth Stocks on Cathie Wood's Buy List Last Week
07:00am, Sunday, 25'th Apr 2021
These three stocks have just one thing in common: The potential for explosive growth.
2 Cathie Wood Picks That Can Become Bigger Winners Than Tesla
08:31am, Thursday, 22'nd Apr 2021
Digital wallets and genomics will transform the world in coming years.
MADISON, Wis., April 14, 2021 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its previously announced acquisition of Ashion Analytics, LLC.
